FDA Inspection 1025749 — ALK-Abello, Inc.

ALK-Abello, Inc. — FEI 3006900385

The FDA completed an inspection of ALK-Abello, Inc. on September 19, 2017 in Plainville, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Plainville, CT (United States)

Citations

IDCFRDescription
143321 CFR 211.42(c)(10)(iii)Air Supply
145121 CFR 211.113(b)Procedures for sterile drug products
180921 CFR 211.160(a)Following/documenting laboratory controls
354721 CFR 211.46(b)Equipment for Environmental Control
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified